Anti-SMAD7 Antibody
Overview
This antibody targets human SMAD family member 7 (SMAD7), an inhibitory regulator of TGF-beta signalling pathways. It is generated using a sequence-defined immunogen to support selective detection in cell-based assays.
Highlights
- Targets human SMAD7 protein
- Sequence-specific immunogen
- Validated for immunocytochemistry (ICC)
- Buffered glycerol-based formulation
At-a-glance
- Target
- SMAD family member 7 (SMAD7)
- Host
- Rabbit
- Clonality
- Polyclonal
- Immunogen sequence
- EVKRLCCCESYGKINPELVCCNPHHLSRLCELESPPPPYSRYPMDFLKPTADCPDAVPSSAETGGTNYLAPGGLSDSQLLLEPGDRSHWCVVAYWEEKTRVGRLYCVQEPSLDIFYDLPQGNG
- Recommended application
- ICC
- Buffer composition
- 40% glycerol and PBS (pH 7.2), with 0.02% sodium azide as preservative
- Condition
- New / Unused — The product is only validated for ICC application
Applications
This antibody is suitable for immunocytochemical analysis of SMAD7 localisation in human cells. It supports studies of TGF-beta signalling and transcriptional regulation.
Sustainability
By rehoming surplus lab products, this listing supports waste reduction and resource efficiency.
